Donna M Wilcock Selected Research

Donna M Wilcock Research Topics

Disease

46	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 12/2004
19	Dementia (Dementias) 01/2024 - 06/2014
14	Amyloid Plaque 01/2022 - 02/2004
10	Cognitive Dysfunction 01/2023 - 06/2014
9	Neuroinflammatory Diseases 11/2023 - 12/2008
9	Hyperhomocysteinemia 09/2023 - 01/2014
6	Inflammation (Inflammations) 01/2023 - 03/2015
6	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019 - 12/2004
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2016
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023 - 01/2014
3	limbic-predominant age-related TDP-43 encephalopathy 08/2023 - 01/2022
3	Tauopathies 01/2018 - 01/2012
3	Disease Progression 07/2014 - 02/2005
3	Memory Disorders (Memory Loss) 01/2006 - 12/2004
2	Down Syndrome (Down's Syndrome) 11/2023 - 10/2023
2	Hemorrhage 09/2011 - 12/2004
1	Gliosis 11/2023
1	Infections 01/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Arteriolosclerosis 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Proteostasis Deficiencies 01/2022
1	Hippocampal Sclerosis 01/2018
1	Atrophy 01/2018
1	Chronic Traumatic Encephalopathy 01/2018
1	Fibrosis (Cirrhosis) 01/2016
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 06/2014
1	Obesity 06/2014
1	Cerebral Hemorrhage 05/2013

Drug/Important Bio-Agent (IBA)

26	Amyloid (Amyloid Fibrils)IBA 11/2023 - 12/2004
16	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2016
13	Amyloid beta-PeptidesIBA 01/2024 - 12/2008
12	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2006
7	Apolipoproteins E (ApoE)IBA 01/2023 - 07/2013
6	Peptides (Polypeptides)IBA 08/2023 - 03/2009
6	ApolipoproteinsIBA 01/2023 - 01/2018
5	HomocysteineIBA 01/2022 - 01/2016
4	Nitric Oxide Synthase (NO Synthase)IBA 12/2012 - 02/2008
4	AntibodiesIBA 05/2006 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 11/2023 - 05/2013
3	Vitamin B Complex (B Vitamins)IBA 01/2023 - 01/2016
2	tau Proteins (tau Protein)IBA 08/2023 - 08/2010
2	ProteomeIBA 08/2023 - 01/2022
2	SynucleinsIBA 08/2023 - 01/2022
2	CytokinesIBA 01/2023 - 07/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 05/2013
2	Islet Amyloid PolypeptideIBA 01/2023 - 01/2021
2	CalcineurinIBA 01/2023 - 01/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2019 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 12/2008
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 12/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 12/2012
1	Glial Fibrillary Acidic ProteinIBA 11/2023
1	Interleukin-10 (Interleukin 10)IBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	CholesterolIBA 09/2023
1	Atorvastatin (Lipitor)FDA Link 09/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	VaccinesIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	CalciumIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Detergents (Detergent)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2020
1	Apolipoprotein E4IBA 01/2020
1	VitaminsIBA 12/2019
1	Methionine (L-Methionine)FDA Link 12/2019
1	Myosin-Light-Chain KinaseIBA 10/2019
1	Pemetrexed (MTA)FDA Link 01/2018
1	CoagulantsIBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 03/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2013
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2013
1	InterleukinsIBA 05/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2012
1	LithiumIBA 01/2012
1	Coloring Agents (Dyes)IBA 01/2006
1	Congo RedIBA 01/2006
1	Adenosine Triphosphatases (ATPase)IBA 02/2005
1	Immunoglobulin G (IgG)IBA 07/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2004

Therapy/Procedure

10	Immunotherapy 01/2017 - 02/2004
6	Therapeutics 04/2024 - 02/2005
1	Injections 12/2004